We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $42.4B
1-Year Est. Return 181.11%
This Fund
S&P 500
This Quarter Est. Return
+6.82%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
AUM
$21B
AUM Growth
+$3.99B
Cap. Flow
-$643M
Cap. Flow %
-3.07%
Top 10 Hldgs %
41.48%
Holding
317
New
46
Increased
82
Reduced
113
Closed
28

Sector Composition

Rank Sector Weight
1 Technology 35.21%
2 Consumer Discretionary 20.16%
3 Financials 14.28%
4 Healthcare 13.93%
5 Communication Services 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRO icon
101
Brown & Brown
BRO
$22.1B
$42.7M 0.2%
412,500
+12,500
+3% +$1.24M
TBBB icon
102
BBB Foods
TBBB
$6.08B
$41.8M 0.2%
+1,392,191
New +$39M
MMSI icon
103
Merit Medical Systems
MMSI
$5.16B
$40.8M 0.19%
412,765
ROIV icon
104
Roivant Sciences
ROIV
$29.5B
$40.4M 0.19%
3,500,000
+2,000,000
+133% +$22.8M
RLI icon
105
RLI Corp
RLI
$5.55B
$40.3M 0.19%
520,000
FIS icon
106
Fidelity National Information Services
FIS
$19.7B
$38.1M 0.18%
454,631
+3,119
+0.7% +$246K
CDNS icon
107
Cadence Design Systems
CDNS
$76.9B
$37.9M 0.18%
139,879
-86,701
-38% -$24M
NUVL
108
DELISTED
Nuvalent
NUVL
$37.1M 0.18%
362,500
+75,000
+26% +$6.22M
LBPH
109
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$36.8M 0.18%
1,102,740
-251,765
-19% -$8.67M
CGON icon
110
CG Oncology
CGON
$6.41B
$36.5M 0.17%
967,055
BEKE icon
111
KE Holdings
BEKE
$18.4B
$34.8M 0.17%
1,745,725
+1,735,539
+17,038% +$25.6M
ASND icon
112
Ascendis Pharma A/S
ASND
$17.3B
$33.6M 0.16%
+225,000
New +$30.4M
IBKR icon
113
Interactive Brokers
IBKR
$41.1B
$32.4M 0.15%
930,552
-82,260
-8% -$2.55M
VTEX icon
114
VTEX
VTEX
$595M
$31.9M 0.15%
4,292,617
+3,102,133
+261% +$21.6M
APLS
115
DELISTED
Apellis Pharmaceuticals
APLS
$31.2M 0.15%
1,082,000
+2,560
+0.2% +$94.8K
CRH icon
116
CRH
CRH
$58.9B
$30.1M 0.14%
324,215
-85,258
-21% -$7.16M
PODD icon
117
Insulet
PODD
$9.15B
$29.6M 0.14%
127,204
-3,677
-3% -$755K
SPGI icon
118
S&P Global
SPGI
$121B
$28.7M 0.14%
55,461
-10,372
-16% -$5.13M
WMT icon
119
Walmart Inc
WMT
$865B
$26.7M 0.13%
330,570
-29,182
-8% -$2.14M
MIRM icon
120
Mirum Pharmaceuticals
MIRM
$6.28B
$26.3M 0.13%
675,000
-66,049
-9% -$2.63M
MCK icon
121
McKesson
MCK
$103B
$25.8M 0.12%
52,254
-79,127
-60% -$44.1M
MLTX icon
122
MoonLake Immunotherapeutics
MLTX
$1.06B
$25.2M 0.12%
500,000
-178,169
-26% -$8.35M
USFD icon
123
US Foods
USFD
$20.6B
$25.1M 0.12%
408,937
-51,187
-11% -$2.86M
NAMS icon
124
NewAmsterdam Pharma
NAMS
$2.73B
$25M 0.12%
1,505,000
+502,414
+50% +$8.69M
ICLR icon
125
Icon
ICLR
$13.1B
$24.4M 0.12%
84,957
-37,615
-31% -$11.9M

Similar funds

Polar Capital Holdings's Q3 2024 Portfolio in Review

As of Q3 2024, Polar Capital Holdings held 317 positions worth $21B, up 24% from $17B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Polar Capital Holdings withdrew a net $643M in Q3 2024, closing 28 positions and reducing 113 holdings. Its most notable exit was Applied Materials, an estimated $140M position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 46% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Polar Capital Holdings opened a new position in MACOM Technology Solutions worth $122M.

  • Polar Capital Holdings's largest Q3 2024 buy was MACOM Technology Solutions: 1,096,992 shares worth $122M.
  • Polar Capital Holdings added most to Mercado Libre in Q3 2024, an estimated $110M increase.
  • Polar Capital Holdings's biggest Q3 2024 reduction was CrowdStrike, cutting an estimated $214M.
  • Polar Capital Holdings fully exited Applied Materials in Q3 2024, selling an estimated $140M.
  • Polar Capital Holdings's ten largest holdings make up 41% of its $21B portfolio in Q3 2024.
  • Polar Capital Holdings opened 46 new positions and closed 28 in Q3 2024.
  • Polar Capital Holdings's portfolio value rose 24% quarter-over-quarter to $21B.

Based on Polar Capital Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.